Vivalytic | STI Array | Randox Laboratories

Solutions
keyboard_arrow_down
Services
keyboard_arrow_down
Support & Resources
keyboard_arrow_down
Company
keyboard_arrow_down

Contact

Download Flyer download Download Methodological article on the Vivalytic STI array download Download Whitepaper download

Comprehensive Sexual Health Profile

detector

Detecting 10 bacterial, viral and protozoan infections

check_circle

The STI array has recently received CE marking

acute

Rapid turnaround time of just 2 hours 20 minutes from sample entry to result

coronavirus

Sample to answer, cartridge based molecular diagnostics at the point of care. Powered by Randox Biochip Technology

barefoot

Simple and easy to use analyser with a small footprint making it suitable for use in laboratory and non-laboratory settings

counter_4

Convenient 4 step process from sample entry to results. No laboratory training required

Clinical Significance

The Sexually Transmitted Infection (STI) array is the broadest multiplex cartridge-based STI test on the market simultaneously detecting 7 bacterial, 2 viral and 1 protozoan infection for a comprehensive sexual health profile.

Globally, each day over 1 million people are exposed to an STI, many of who will not know they have an infection as many STI’s are asymptomatic whilst some individuals will display similar or overlapping symptoms, therefore co-infections may remain undiagnosed. Designed to offer a complete sexual health profile with an aim of prevention and control, the Vivalytic STI array can be used to diagnose existing infections whilst any identifying co-infections.

To find out more about the global economic burden of STIs and the impact of the COVID-19 pandemic on sexual health, download our most recent whitepaper that presents issues such as AMR, the development of super-gonorrhoea, and the challenges faced in a social and public concept due to the COVID-19 pandemic.

Features

Sample Type	Swab or Urine (eNAT, Roche COBAS medium, or PBS)
Sample Volume	300 μl
Detection Method	Randox Biochip Technology (end-point PCR)
Time to result	2 hours 20 minutes

Detectable Infections
Chlamydia trachomatis (CT)	Herpes simplex virus 1 (HSV-1)
Neisseria gonorrhoeae (NG)	Herpes simplex virus 2 (HSV-2)
Trichomonas vaginalis (TV)	Haemophilus ducreyi (HD)
Mycoplasma genitalium (MG)	Mycoplasma hominis (MH)
Treponema pallidum (Syphilis) (TP)	Ureaplasma urealyticum (UU)

"AWARD-WINNING DESIGN DELIVERS AN UNCOMPLICATED USER EXPERIENCE"

Vivalytic Workflow

Intuitive engineering of Vivalytic ensures the analyser is user friendly. The process of patient sample to result comprises a very simple 4 step workflow.

To begin the test, the user scans or enters sample information. The cartridge code is then scanned into the embedded Vivalytic software. The user then adds sample into the dedicated cartridge slot, closes the lid and inserts the cartridge into the Vivalytic.

The touchscreen display will countdown the time remaining to test completion. Results will be displayed on the screen. Multiple Vivalytics can be wirelessly connected allowing the user to control multiple tests at one time all reporting to a master Vivalytic platform.